The Journal of Heart and Lung Transplantation
Volume 26, Issue 10 , Pages 1054-1060 , October 2007

Fibrinolytic Treatment Improves the Quality of Lungs Retrieved From Non-Heart-Beating Donors

Presented at the Twenty-seventh Annual Meeting and Scientific Sessions of International Society for Heart and Lung Transplantation, San Francisco, California, April 25–28, 2007.

  • Ilhan Inci, MD

      Affiliations

    • University Hospital, Division of Thoracic Surgery, University of Zurich, Zurich, Switzerland
    • Corresponding Author InformationReprint requests: Ilhan Inci, MD, University of Zurich, Division of Thoracic Surgery, Raemistrasse 100, 8091 Zurich, Switzerland. Telephone: 0041-44-255-88-02.
    • ,
  • Wei Zhai, MD

      Affiliations

    • University Hospital, Division of Thoracic Surgery, University of Zurich, Zurich, Switzerland
    • ,
  • Stephan Arni, PhD

      Affiliations

    • University Hospital, Division of Thoracic Surgery, University of Zurich, Zurich, Switzerland
    • ,
  • Demet Inci, MD

      Affiliations

    • University Children’s Hospital Division of Respiratory Medicine, University of Zurich, Zurich, Switzerland
    • ,
  • Sven Hillinger, MD

      Affiliations

    • University Hospital, Division of Thoracic Surgery, University of Zurich, Zurich, Switzerland
    • ,
  • Didier Lardinois, MD

      Affiliations

    • University Hospital, Division of Thoracic Surgery, University of Zurich, Zurich, Switzerland
    • ,
  • Peter Vogt, MD

      Affiliations

    • Deparment of Pathology, University of Zurich, Zurich, Switzerland.
    • ,
  • Walter Weder, MD

      Affiliations

    • University Hospital, Division of Thoracic Surgery, University of Zurich, Zurich, Switzerland

Received 2 May 2007 ,Revised 13 July 2007 ,Accepted 18 July 2007.

References 

  1. Wierup P, Haraldsson A, Nilsson F, et al. Ex vivo evaluation of nonacceptable donor lungs. Ann Thorac Surg. 2006;81:460–466
  2. Pierre AF, Sekine Y, Hutcheon MA, et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg. 2002;123:421–427
  3. Artemiou O, Birsan T, Taghavi S, et al. Bilateral lobar transplantation with the split lung technique. J Thorac Cardiovasc Surg. 1999;118:369–370
  4. Cohen RG, Starnes VA. Living donor lung transplantation. World J Surg. 2001;25:244–250
  5. Steen S, Söberg T, Pierre L, et al. Transplantation of lungs from a non-hear-beating donor. Lancet. 2001;357:825–829
  6. Persijn GG, Cohen B. Donation, waiting list, and transplants (Annual Report of 2001 of the Eurotransplant International Foundation). In: Leiden, The Netherlands: Eurotransplant International Foundation; 2001;p. 41–52
  7. The Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549–556
  8. De Antonio DG, Marcos R, Laporta R, et al. Results of clinical lung transplant from uncontrolled non-heart-beating donors. J Heart Lung Transplant. 2007;26:529–534
  9. Love RB, D’Allesandro AM, Cornwell RA, Meyer KM. Ten year experience with human lung transplantation from non-heart beating donors. J Heart Lung Transplant. 2003;22(suppl):S87
  10. Erasmus ME, Van Der Bij W, Verschuuren EAM. Non-heart-beating lung donation in The Netherlands: the first experience. J Heart Lung Transplant. 2006;25(suppl):S63
  11. Egan TM, Haithcock JA, Nicotra WA, et al. Ex vivo evaluation of human lungs for transplant suitability. Ann Thorac Surg. 2006;81:1205–1213
  12. Neyrinck A, Rega F, Jannis N, et al. Ex vivo reperfusion of human lungs declined for transplantation (A novel approach to alleviate donor organ shortage). J Heart Lung Transplant. 2004;23:S172–S173
  13. Toombs CF. New directions in thrombolytic therapy. Curr Opin Pharmacol. 2001;1:164–168
  14. Kootstra G. The asystolic, or non-heartbeating, donor. Transplantation. 1997;63:917–921
  15. Kuroe K, Kurokawa T, Nishikimi M, et al. Effects of thromboxane A2 synthetase inhibitor on postischemic liver injury in rats. Eur Surg Res. 1991;23:20–26
  16. Okazaki M, Date H, Inokawa H, et al. Optimal time for post-mortem heparinization in canine lung transplantation with non-heart-beating donors. J Heart Lung Transplant. 2006;25:454–460
  17. Umemori Y, Date H, Uno K, Aoe M, Ando A, Shimizu N. Improved lung function by urokinase infusion in canine lung transplantation using non-heart-beating donors. Ann Thorac Surg. 1995;59:1513–1518
  18. Akasaka S, Nishi H, Aoe M, Date H, Andou A, Shimizu N. The effects of recombinant tissue-type plasminogen activator (rt-PA) on canine cadaver lung transplantation. Surg Today. 1999;29:747–754
  19. Sugimoto R, Date H, Sugimoto S, et al. Post-mortem administration of urokinase in canine lung transplantation from non-heart-beating donors. J Heart Lung Transplant. 2006;25:1148–1153
  20. Hirota M, Ishino K, Fukumasu I, et al. Prediction of functional recovery of 60-minute warm ischemic hearts from asphyxiated canine non-heart-beating donors. J Heart Lung Transplant. 2006;25:339–344
  21. Suehiro K, Mohri M, Yamaguchi H, et al. Posttransplant function of a nonbeating heart is predictable by an ex vivo perfusion method. Ann Thorac Surg. 2001;71:278–283
  22. Minor T, Hachenberg A, Tolba R, Pauleit D, Akbar S. Fibrinolytic preflush upon liver retrieval from non-heart beating donors to enhance postpreservation viability and energetic recovery upon reperfusion. Transplantation. 2001;71:1792–1796
  23. Yamauchi J-I, Richter S, Vollmar B, Menger MD, Minor T. Warm preflush with streptokinase improves microvascular procurement and tissue integrity in liver graft retrieval from non-heart-beating donors. Transplantation. 2000;69:1780–1784
  24. Yamauchi J, Schramm R, Richter S, Vollmar B, Menger MD, Minor T. Improvement of microvascular graft equilibration and preservation in non-heart-beating donors by warm preflush with streptokinase. Transplantation. 2003;75:449–453
  25. Gok MA, Shenton BK, Peaston R, et al. Improving the quality of kidneys from non-heart-beating donors, using streptokinase: an animal model. Transplantation. 2002;73:1869–1874
  26. Gok MA, Shenton BK, Buckley PE, et al. How to improve the quality of kidneys from non-heart-beating donors: a randomised controlled trial of thrombolysis in non-heart-beating donors. Transplantation. 2003;76:1714–1719
  27. Steen S, Liao Q, Wierup PN, et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex-vivo. Ann Thorac Surg. 2003;76:244–256
  28. Stroughton J, Ouriel K, Shortell CK, Cho JS, Marder VJ. Plasminogen acceleration of urokinase thrombolysis. J Vasc Surg. 1994;19:298–303
  29. Pechlaner C, Knapp E, Wiedermann CJ. Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase. Blood Coagul Fibrinolysis. 2001;12:491–494
  30. Franco S, Kelly M, Ushay M, DiMichele D. Highly probable anaphylactic reaction to systemic thrombolytic therapy with high dose urokinase in a child with a prosthetic valve. J Pediatr Hematol Oncol. 1998;20:181–182

 Sorin Group (Italy) provided the oxygenators, and Vitrolife (Göteburg, Sweden) provided the Perfadex.

PII: S1053-2498(07)00578-5

doi: 10.1016/j.healun.2007.07.033

The Journal of Heart and Lung Transplantation
Volume 26, Issue 10 , Pages 1054-1060 , October 2007

Article Tools

* Image Usage & Resolution